Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03294460 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nicotinic Receptor Genetic Variation and Alcohol Reward

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 701 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 30 words
  2. Minor 14 versions Re-verified since Apr 14, 2026, no change to tracked fieldsv687-v700
  3. Minor Study Status, Study Description, Eligibilityv686
  4. Minor 3 versions Re-verified since Feb 19, 2026, no change to tracked fieldsv683-v685
  5. Notable Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v682
Show 30 earlier versionsHide 30 earlier versions
  1. Minor 21 versions Re-verified since Jan 31, 2025, no change to tracked fieldsv661-v681
  2. Notable Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v660
  3. Minor 8 versions Re-verified since Sep 18, 2024, no change to tracked fieldsv652-v659
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: People with the brain disease AUD (alcohol use disorder) have a serious problem with drinking. Researchers want to study how different people react to alcohol, and how genes affect this. They will focus on a nicotine receptor gene that may increase a person s AUD risk. Objectives: To see if people with variations of a nicotine receptor gene take alcohol differently and have different brain responses to alcohol cues. Eligibility: Healthy adults ages 21 - 60. This study includes smokers and non-smokers. Design: Participation will be based on evaluation under the NIAAA natural history protocol (14-AA-0181) or a screening visit under this protocol. Participants will have two 9-hour visits. They must have no alcohol or non-prescription drugs before all visits and no food or drink before the first visit. At every visit, participants will: * Get a light meal * Have breath and urine tests * Get taxi rides there and back At visits 1, participants will: * Have a thin plastic tube inserted in an arm and connected to a pump for alcohol infusion. * Have sensors on their chest to monitor heart rate. * Sit in a chair for 2.5 hours and get alcohol by pushing a button. Their breath alcohol level will be monitored. * Answer questions about mood and effects of alcohol * Give blood samples * Relax at the clinic while their breath alcohol level drops At visit 2, participants will: * Answer questions and do computer tests * Have an alcoholic drink and a snack * Have a magnetic resonance imaging (MRI) scan. They will lie in a machine that takes pictures of the brain. They will do computer tasks. * Have another drink and snack * Relax until their alcohol level drops Participants will have a follow-up call after each visit.
Trial Details
NCT Number NCT03294460
Lead Sponsor National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions
(from sponsor)
Alcohol Drinking
Related terms Alcohol Drinking, Smoking
Enrollment 128 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov